Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease

Circulation

Volumn 103, Issue 10, 2001, Pages 1386-1389

  Wu, Kenneth K ^a,c   Aleksic, Nena ^a   Ahn, Chul ^a   Boerwinkle, Eric ^a   Folsom, Aaron R ^b   Juneja, Harinder ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Coronary disease; Genetics; Thrombomodulin

Indexed keywords

ALANINE; AMINO ACID; THROMBOMODULIN; VALINE;

ACUTE HEART INFARCTION; ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MALE; NEGRO; PRIORITY JOURNAL;

EID: 0035853133     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.10.1386     Document Type: Article

References (23)

1. Structure and function of thrombomodulin: A novel anticoagulant
2. Thrombomodulin as a model of molecular mechanism that modulates protease specificity and function at the vessel surface
3. Heterogenous regulation of constitutive thrombomodulin on inducible tissue factor activities on the surface of human saphenous vein endothelial cells in culture following stimulation by interleukin-1, tumor necrosis factor, thrombin or phorbol ester
4. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vivo
5. Human thrombomodulin gene is deleted: Nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control
6. A frequent thrombomodulin amino acid dimorphism is not associated with thrombophilia
7. The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease
8. Thrombomodulin gene mutations associated with myocardial infarction
9. A novel thrombomodulin gene mutation in a patient suffering from sagittal sinus thrombosis
10. A common thrombomodulin dimorphism is associated with myocardial infarction
11. The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives
12. Differences between respondents and non-respondents in a multicenter community-based study vary by gender and ethnicity
13. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk In Communities (ARIC) study
14. A case-cohort design for epidemiologic cohort studies and disease prevention trials
15. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study: Methods and initial two years experience
16. A short questionnaire for the measurement of habitual physical activity in epidemiological studies
17. ARIC hemostasis study, I: Development of blood collection and processing system suitable for multicenter hemostatic studies
18. Reagent for the enzymatic determination of total serum cholesterol with improved lipolytic efficiency
19. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol
20. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk In Communities (ARIC) study: A case-control study
21. Robust variance estimation for the case-cohort design
22. Analysis of thrombomodulin gene polymorphism in women with severe early onset pre-eclampsia
23. Plasma concentration of interleukin-6 and risk of future myocardial infarction among apparently healthy men